title: The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.
authors.affiliation: Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath BA1 1RL, UK. neil.mchugh@rnhrd.nhs.uk.
authors.forename: Laura C
authors.initials: LC
authors.lastname: Coates
authors.forename: William
authors.initials: W
authors.lastname: Tillett
authors.forename: David
authors.initials: D
authors.lastname: Chandler
authors.forename: Philip S
authors.initials: PS
authors.lastname: Helliwell
authors.forename: Eleanor
authors.initials: E
authors.lastname: Korendowych
authors.forename: Stuart
authors.initials: S
authors.lastname: Kyle
authors.forename: Iain B
authors.initials: IB
authors.lastname: McInnes
authors.forename: Susan
authors.initials: S
authors.lastname: Oliver
authors.forename: Anthony
authors.initials: A
authors.lastname: Ormerod
authors.forename: Catherine
authors.initials: C
authors.lastname: Smith
authors.forename: Deborah
authors.initials: D
authors.lastname: Symmons
authors.forename: Nicola
authors.initials: N
authors.lastname: Waldron
authors.forename: Neil J
authors.initials: NJ
authors.lastname: McHugh
mesh_terms: D000465:Algorithms; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha
keywords: anti-TNF therapies; biologics; dactylitis; enthesitis; guidelines; management; psoriasis; psoriatic arthritis; recommendations; treatment